ISIN | LU2591956839 |
---|---|
Valor Number | 125205293 |
Bloomberg Global ID | UBHELUX LX |
Fund Name | UBS (Lux) Equity SICAV - Healthy Living (USD) U-X-acc |
Fund Provider |
UBS Asset Management Switzerland AG, Zurich
Basel, Switzerland Phone: +41 61 288 75 01 E-Mail: sh-ubs-funds-feedback@ubs.com Web: www.ubs.com/fonds |
Fund Provider | UBS Asset Management Switzerland AG, Zurich |
Representative in Switzerland |
UBS Fund Management (Switzerland) AG Basel Phone: +41 61 288 49 10 |
Distributor(s) | |
Asset Class | Equities |
EFC Category | Equity Health Care |
Distribution Policy | Accumulation |
Home Country | Luxembourg |
Issuing Condition | The fund does not charge any issuing commission and/or fees (units are issued at the NAV) |
Redemption Condition | The fund does not charge any redemption commission and/or fees (units are redeemed at the NAV) |
Investment Strategy *** | UBS Asset Management categorises this sub-fund as a Sustainability Focus Fund. This sub-fund promotes environmental and/or social characteristics and complies with Article 8 of Regulation (EU) 2019/2088 on sustainability-related disclosures in the financial services sector (“SFDR”). This actively managed sub-fund invests at least 80% of its assets in equities and other equity interests of companies in developed and emerging markets worldwide that have exposure to sustainable themes which the Portfolio Manager considers to be critical to the trend of healthy living and disease prevention. Those include but are not limited to, healthy lifestyle, healthy nutrition, consumerization of health, disease prevention, mental well-being and longevity. Lifespan increased significantly over the past century, yet the time spent in a healthy state (i.e. health span) still lags behind. |
Peculiarities |
Current Price * | 11,191.57 USD | 14.11.2024 |
---|---|---|
Previous Price * | 11,326.71 USD | 13.11.2024 |
52 Week High * | 11,776.88 USD | 27.09.2024 |
52 Week Low * | 9,420.77 USD | 16.11.2023 |
NAV * | 11,191.57 USD | 14.11.2024 |
Issue Price * | 11,191.57 USD | 14.11.2024 |
Redemption Price * | 11,191.57 USD | 14.11.2024 |
Closing Price * | ||
Indicative Minimum Price | ||
Fund Assets *** | 4,628,022 | |
Unit/Share Assets *** | 4,300,669 | |
Trading Information SIX |
YTD Performance | +9.04% |
29.12.2023 - 14.11.2024
29.12.2023 14.11.2024 |
---|---|---|
YTD Performance (in CHF) | +15.35% |
29.12.2023 - 14.11.2024
29.12.2023 14.11.2024 |
1 month | -3.95% |
14.10.2024 - 14.11.2024
14.10.2024 14.11.2024 |
3 months | +0.50% |
14.08.2024 - 14.11.2024
14.08.2024 14.11.2024 |
6 months | +0.63% |
14.05.2024 - 14.11.2024
14.05.2024 14.11.2024 |
1 year | +18.40% |
14.11.2023 - 14.11.2024
14.11.2023 14.11.2024 |
2 years | +12.37% |
06.07.2023 - 14.11.2024
06.07.2023 14.11.2024 |
3 years | - | - |
5 years | - | - |
Equity Participation Rate in % | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Share of Total Fund Assets in % | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Real Estate Rate in % | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
ADDI | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
ADDI Date |
Koninklijke Philips NV | 6.92% | |
---|---|---|
Danone SA | 6.19% | |
Eli Lilly and Co | 5.49% | |
Haleon PLC | 5.16% | |
Mowi ASA | 4.01% | |
Novo Nordisk AS Class B | 3.90% | |
Alcon Inc | 3.86% | |
Shimano Inc | 3.51% | |
Novonesis (Novozymes) B Class B | 3.19% | |
Cava Group Inc | 3.01% | |
Last data update | 30.09.2024 |
TER | |
---|---|
TER date | |
Performance Fee *** | 0.00% |
PTR | |
Max. Management Fee *** | 0.00% |
Ongoing Charges *** | |
SRRI ***
|
|
SRRI date *** | 31.10.2024 |
Low Carbon Designation *** | |
---|---|
ESG Rating Overall *** | |
ESG Rating Corporate *** | |
ESG Rating Sovereign *** | |
% AuM H&S Controversies *** |
Avg Carbon Risk Score *** | |
---|---|
Avg Carbon Risk Cat Avg *** | |
% AuM Covered Carbon *** | |
Avg Fossil Fuel Exposure *** | |
Fossil Fuel Cat Avg *** |
Strategy Level 1 *** | |
---|---|
Strategy Level 2 *** | |
Strategy Level 3 *** | |
Exclusions Level 1 *** | |
Exclusions Level 2 *** |